rophibio.co.kr valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
Sitemap: http://rophibio.co.kr/wp-sitemap.xml
Meta Tags
Title ROPHIBIO
Description KOREAN English ROPHIBIO Primary Menu Skip to content 회사소개 회사소개 연혁 인사말 조직도 오시는 길 기술소개 인조 유전자프로모터 기술 형질개량형 CHO세포기술 세포주개발 및 생산/정제기술 줄기세포기술 파이프라인 바이오의약품 신약파이프
Keywords N/A
Server Information
WebSite rophibio faviconrophibio.co.kr
Host IP 50.63.92.10
Location United States
Related Websites
Site Rank
More to Explore
rophibio.co.kr Valuation
US$449,573
Last updated: 2022-12-13 07:38:58

rophibio.co.kr has Semrush global rank of 23,543,037. rophibio.co.kr has an estimated worth of US$ 449,573, based on its estimated Ads revenue. rophibio.co.kr receives approximately 51,874 unique visitors each day. Its web server is located in United States, with IP address 50.63.92.10. According to SiteAdvisor, rophibio.co.kr is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$449,573
Daily Ads Revenue US$415
Monthly Ads Revenue US$12,450
Yearly Ads Revenue US$149,397
Daily Unique Visitors 3,459
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
rophibio.co.kr. A 600 IP: 50.63.92.10
rophibio.co.kr. NS 3600 NS Record: ns68.domaincontrol.com.
rophibio.co.kr. NS 3600 NS Record: ns67.domaincontrol.com.
HtmlToTextCheckTime:2022-12-13 07:38:58
KOREAN English ROPHIBIO Primary Menu Skip to content 회사소개 회사소개 연혁 인사말 조직도 오시는 길 기술소개 인조 유전자프로모터 기술 형질개량형 CHO세포기술 세포주개발 및 생산/정제기술 줄기세포기술 파이프라인 바이오의약품 신약파이프라인 바이오시밀러 후보물질 뉴스/공지사항 Menu Home > > Home 슬라이더1 슬라이더2 슬라이더3 < > Home 뉴스/공지사항 Title Date 충북대 홍진태 교수, (주)로피바이오 신약개발 미국특허 2019.11.25 충청북도, 바이오 기업 해외진출 교두부 마련 2019.11.25 주식액면분할 및 주권제출공고 2019.08.01 [서울경제] 함성호 라파젠 대표 2016.12.19 Biotherapeutics Gene Therapy Stem Cell Therapy Protein/Antibody Therapy Treatment for autoimmune disease and cancer Stem Cell Technologies Adipose derived stem cell culturing and banking GMP certified processing Safe, effective, high-quality Biosimilars Highly productive cell lines Bioequivalence proven Industry leading clinical and animal studies Cell Line Development Gene amplification not required Pre-adaptation to suspension culture Guaranteed clonality About Rophibio 첨단 바이오 의약품 기술을 활용한 현식적인 의약품 개발 view more+ Contact us the values of cooperation and teamwork view more+ Korea Office 301, 194-41,
HTTP Headers
HTTP/1.1 200 OK
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
Content-Length: 0
Content-Type: text/html; charset=UTF-8
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Server: Microsoft-IIS/10.0
Set-Cookie: PHPSESSID=9i2vhih9sdg08ob4tihdling7l; path=/
Link: ; rel="https://api.w.org/"
Link: ; rel="alternate"; type="application/json"
Link: ; rel=shortlink
X-Powered-By: ASP.NET
X-Powered-By-Plesk: PleskWin
Date: Sat, 13 Aug 2022 08:49:03 GMT